1 SUPPLEMENT S2: RT-QPCR METHODS Table S2.1 Experimental design Definition of experimental and control groups Number in ...
SUPPLEMENT S2: RT-QPCR METHODS Table S2.1 – Experimental design Definition of experimental and control groups Number in each group Assay carried out by core or investigator's laboratory
Experimental: Madison (MSN) mouse strain. Control: outbred hsd:ICR (ICR) mouse strain. 8 MSN, 8 ICR. All mice were male.
Authors’ contributions to qPCR section
C. Michael Saul: all molecular work, half of dissection work, writing. Griffin M. Gessay: half of dissection work. Stephen C. Gammie: bred mice, provided funding and lab space, writing.
Carried out in investigator's laboratory.
Table S2.2 – Tissue Samples Description Volume or Mass of sample Dissection Type Processing Procedure If frozen, how quickly? Sample storage conditions
Fresh frozen whole hippocampus. See table S2.10. Gross dissection of hippocampal tissue from brain. Animals were euthanized by cervical dislocation under isoflurane anesthetic, decapitated, and their hippocampi were immediately dissected from their brains. Samples frozen immediately on dry ice upon dissection. Stored at -80°C for no more than 12 weeks prior to RNA extraction.
Table S2.3 – Nucleic Acid Extraction Procedure and/or instrumentation Name of kit and details of any modifications Sources of additional reagents used
Mortar and pestle disruption, guanidinium thiocyanate-phenol-chloroform extraction, and spin column cleanup and purification. Bio-Rad Aurum Total RNA Fatty and Fibrous Tissue Kit (catalog number 7326830) used according to the manufacturer’s specifications. Chloroform (Acros Organics, catalog number AC42355-0250) Ethanol (Fisher Scientific, catalog number BP2818-500)
Details of DNase treatment
On-column treatment with DNase I according to manufacturer's specifications.
Contaminaion assessment of input RNA
NanoDrop curves used to assess presence of presence of protein, salt, and organic contaminants. All curves indicated clean samples.
Nucleic acid quantification
See table S2.10.
Instrument and method of nucleic acid quantification
NanoDrop spectrophotometer, absorbance at 260nm.
Purity (A260/A280)
See table S2.10.
Yield
See table S2.10.
RNA integrity instrument
Agilent RNA 6000 Nano Chips with Agilent BioAnalyzer 2100.
RIN
See table S2.10.
Inhibition testing
Cq dilution, 1:8 using Ywhaz. As expected, diluted samples ran ~3 cycles behind undiluted samples.
Table S2.4 – Reverse Transcription Complete reaction conditions Amount of RNA and reaction volume Priming oligonuclotide and concentration Temperature and time Manufacturer of reagents and catalog number Cq with and without RT Storage conditions of cDNA
500µM dNTP mix, 20mM Tris-HCl (pH 8.4), 50mM KCl, 5mM MgCl2, 2.5mM dT 20mers, 10mM DTT, 2U/µL RNaseOUT, 10U/µL SuperScript III RT. 25µL reactions, 2µg total RNA used in each reaction. 1.25µL RNAse H added after reaction termination. oligo-dT 20mers, final reaction concentration of 2.5mM. Prior to cDNA synthesis, RNA, primers, and dNTPs were denatured together at 65°C for 5 min. cDNA synthesis took place at 50°C for 50 min followed by an 85°C reaction termination step for 5 min. After reaction termination, the RNase reaction ran at 37°C for 20 min. Invitrogen SuperScript III First-Strand Synthesis System for RT-PCR (catalog number 18080-051) See table S2.10 for no RT Cqs. While some gDNA contamination is present, its effect on experiments are negligible and stochastic according to hypothesis testing on no RT controls. This contamination is mostly a source of random error. Stored at -80°C for no longer than 6 months.
Table S2.5 – qPCR Target Information Gene symbol
See table S2.11.
Accession number
See table S2.11.
Location of amplicon
See table S2.11.
Amplicon length
See table S2.11.
In silico specificity
All primers screened for specificity using NCBI Primer-BLAST.
hom*ologs amplified
No primers amplified pseudogenes or retropseudogenes.
Sequence alignment
Aligned in NCBI Primer-BLAST.
Location of each primer by exon or intron
See table S2.11.
Targeted splice variants
Each primer set targets all splice variants for every transcript of interest as they are documented in the NCBI RefSeq RNA database.
Table S2.6 – qPCR oligonucleotides Primer sequences
See table S2.11.
Probe sequences
Not applicable; dsDNA binding dye chemistry used.
Location and identity of any modifications Manufacturer of oligonucleotides Purification method
No modifications. UW-Madison Biotechnology Center DNA Synthesis Facility. Standard desalting and lyophilization.
Table S2.7 – qPCR protocol Complete reaction conditions
2X Bio-Rad SsoFast EvaGreen Super Mix without ROX (catalog number 1725204) used with no modifications.
Reaction volume and amount of cDNA/DNA
20µL reactions; 2µL 1:5 diluted cDNA used in each reaction.
Primer Concentration
500nM forward and 500nM reverse primer for all primer sets.
Mg2+concentration
3.0mM MgCl2.
dNTP concentration
200µM each of dATP, dTTP, dCTP, and dGTP. 800µM dNTP total.
Polymerase identity
Bio-Rad SsoFast Taq Fusion Polymerase.
Polymerase concentration
Proprietary concentration.
Buffer identity and manufacturer
Bio-Rad qPCR buffer provided with SsoFast EvaGreen Supermix.
Exact buffer chemistry
Proprietary composition.
PCR additives used
No additives used.
Manufacturer of plates and catalog number
Applied Biosystems MicroAmp Fast 96-Well Reaction Plates (catalog number 4346907). Incubation stage: 30s at 95°C. Cycling stage: 40 cycles, 3 steps: 5s at 95°C, 20s at annealing temperature (see table S2.11 for the specific annealing temperature used with each primer set), and 20s at 72°C.
Complete thermal cycling parameters Reaction setup
Manual using Eppendorf single channel adjustable volume pipettes.
qPCR instrument
Applied Biosystems StepOnePlus.
Table S2.8 – qPCR validation Evidence of optimization Specificity Cq of NTC Calibration curves with slope and y-intercept (m, b) Efficiency calculated from slope
Prior to analysis, we ran each primer set at several annealing temperatures. We used the annealing temperature with the earliest Cq and the highest efficiency. Stringent in silico testing of primers prior to qPCR using Primer-BLAST, dissociation curve test of specificity in vitro. Cq > 40 for all NTCs for all genes. See table S2.12. See table S2.12.
r2 of calibration curve
See table S2.12.
Linear dynamic range (LDR)
See table S2.12.
Cq variation at Limit of Detection
LOD measurements not necessary for relative quantification.
Evidence for LOD
LOD measurements not necessary for relative quantification.
If multiplex, efficiency and LOD for each assay
Not applicable; dsDNA binding dye chemistry used.
Table S2.9 – Data analysis qPCR analysis program
Relative Expression Software Tool (REST)
Method of Cq determination
Used ABI StepOnePlus software to determine ABI’s Ct value.
Outlier identification and disposition
Our experiments contain no outliers.
Results from NTC
All NTCs have no amplification.
Justification of number and choice of reference genes
The combination of Sdha and Ywhaz was found to be the most stable combination of reference genes by Gubern et al. (2009).
Description of normalization
Data normalized for baseline fluorescence.
Number and stage (reverse transcription or qPCR) of technical replicates Statistical methods for results significance Software (source, version) of stats
3 qPCR technical replicates. Randomization test for significance. StepOnePlus 2.1; REST 2009.
Table S2.10 – Sample quality control
†
ID
Strain
Tissue Mass
RNA Concentration
RNA Yield
Cq (RT/no RT)†
A260 : A280
RIN
1
MSN
35.8 mg
222.34 ng/µL
35.574 µg
18.20/36.78*
2.11
8.2
*
2.12
8.3
2
MSN
36.7 mg
248.83 ng/µL
39.813 µg
17.84/40.00
3
MSN
35.7 mg
271.41 ng/µL
43.426 µg
18.01/31.40
1.99
8.3
*
2.12
8.2
4
MSN
35.8 mg
235.50 ng/µL
37.680 µg
17.75/38.96
5
MSN
60.0 mg
454.53 ng/µL
72.725 µg
18.09/36.62
2.08
8.4
6
MSN
48.2 mg
331.09 ng/µL
52.974 µg
17.88/35.23
2.11
8.2
7
MSN
41.0 mg
290.64 ng/µL
46.502 µg
17.83/38.10*
2.11
8.5
*
2.11
8.3
8
MSN
46.0 mg
263.10 ng/µL
42.096 µg
17.78/38.97
9
ICR
50.7 mg
347.06 ng/µL
55.530 µg
18.03/34.77
2.09
8.5
10
ICR
32.2 mg
215.83 ng/µL
34.533 µg
17.66/36.45
2.12
8.2
11
ICR
44.2 mg
261.85 ng/µL
41.896 µg
17.77/33.17
2.13
8.3
*
2.12
8.3
12
ICR
38.2 mg
247.66 ng/µL
39.626 µg
17.83/39.20
13
ICR
42.0 mg
278.96 ng/µL
44.634 µg
17.97/37.30*
2.11
8.9
*
2.12
8.7
14
ICR
37.2 mg
274.48 ng/µL
43.917 µg
17.98/38.91
15
ICR
30.7 mg
236.85 ng/µL
37.896 µg
17.83/36.06
2.12
9.2
16
ICR
43.3 mg
288.02 ng/µL
46.083 µg
18.02/35.53
2.12
9.4
RT versus no RT data were collected using the reference gene Ywhaz. Cq = 40 indicates no amplification detected.
*No amplification was detected in at least 1 of the replicates in these no RT controls.
Table S2.11 – Primers Gene Symbol
RefSeq Accession
Ywhaz
NM_01174
Sdha
NM_02328
P2x7
NM_011027
Epor
NM_010149
Fhit
NM_010210
Cmklr1
NM_00815
Npsr1
NM_175678
Tac1
NM_009311
Cat
NM_009804
Product Length
Primer Sequence (5’-3’) F: TCCTTATTCCCTCTTGGCAG R: ATGGAAGCTACATTAGCGGTTT F: CCGCTCCTACTGATGAAACC R: GCGCAACTCAATCCCTTAC F: CGAATTATGGCACCGTCAA R: TCTCCGTCACCTCTGCTATG F: GTCCGATTCTGGCATCTCA R: GGACAAGGCTGTTCTCATAG F: CAAACGATTCCCAAGGCATAA R: GGGTACAATAAAGAGTGGTTAG F: ATCTTACACCATCATGCCACG R: GTATACACACTGAAGCAAAGAGC F: GTAGAGGAGCCAATTAACAAGTA R: TAGACCAGAACTTGACAGAGAT F: ACGCACTATCTATTCATCTTCATC R: AGAATTACAAGGCTTATTGGCA F: TTCCCACTTGGATTATGTTGATG R: CTGAAAGCAACCAAACACGG
92 bp 179 bp 150 bp 107 bp 89 bp 95 bp 106 bp 167 bp 119 bp
Amplicon Location Exon 5; 2432-2523 (3’ UTR) Exon 12; 2015-2193 (ORF, 3’ UTR) Exons 1, 2; 234-383 (ORF) Exon 8; 1519-1625 (ORF) Exon 7; 697-763 (3’ UTR) Exon 3; 2003-2097 (3’ UTR) Exon 10; 2866-2971 (3’ UTR) Exon 7; 502-668 (3’ UTR) Exon 13; 2358-2476 (3’ UTR)
Tm 58°C 58°C 57°C 58°C 58°C 58°C 57°C 58°C 56°C
Table S2.12 – qPCR quality control Gene Symbol
PCR Efficiency
Linear Dynamic Range
r2
Slope
y Intercept
Ywhaz Sdha P2x7 Epor Fhit Cmklr1 Npsr1 Tac1 Cat
98.375% 97.271% 96.354% 99.573% 104.902% 98.375% 99.305% 97.414% 97.228%
Cq: 17.60-27.71 Cq: 17.97-28.19 Cq: 27.06-33.29 Cq: 25.42-31.47 Cq: 26.25-33.86 Cq: 27.92-35.92 Cq: 30.68-34.69 Cq: 23.69-29.79 Cq: 28.24-34.31
0.998 0.998 0.989 0.998 0.990 0.994 0.989 0.997 0.987
-3.362 -3.389 -3.412 -3.332 -3.210 -3.362 -3.339 -3.385 -3.390
25.020 25.472 34.583 32.743 33.346 35.382 38.136 31.181 35.793